Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
Jussi Hirvonen(National Institute of Mental Health), Robert B. Innis(National Institutes of Health), Nora D. Volkow(National Institute on Drug Abuse), Robert S. Goodwin(National Institute on Drug Abuse), Cheryl L. Morse(National Institute of Mental Health), Marilyn A. Huestis(Smithsonian Institution), Victor W. Pike(National Institute of Mental Health), Garth E. Terry(National Institute of Mental Health), Sami S. Zoghbi(National Institute of Mental Health), Cheng‐Ta Li(National Institute of Mental Health)
Cited by 582
Related Papers
Neurocircuitry of Addiction
|Neuropsychopharmacology|2009|5.2k
Human Cannabinoid Pharmacokinetics
|Chemistry & Biodiversity|2007|1.1k
Addiction: Beyond dopamine reward circuitry
|Proceedings of the National Academy of Sciences|2011|935
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
|JAMA Psychiatry|2016|856
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
|Drug and Alcohol Dependence|2014|697